Skip to content

Farzan Clinical Research Provides Statistical Analysis Service to Roche Pharma Company

Farzan Clinical Research Provides Statistical Analysis and Protocol writing Services to Iranian Branch of Roche Pharmaceutica Company – Akbarieh Company. The main fields of the studies are Gastric Cancer and Lung Cancer.

Farzan Clinical Research is the first Iranian Clinical Research Organization (CRO). Farzan Clinical Research is now an important partner for many Universities, research centers, scientific societies as well as pharmaceutical and medical device industry. After 10 years experience in providing medical research services as Farzan Institute for Science, Research & Technology, Farzan Clinical Research was founded in Feb 2008 as the first Iranian registered CRO and now offers Clinical Trial Management, Clinical Trial Monitoring, Data Management, Biostatistics and Medical Writing services. Farzan Clinical Research is certified by Ministry of Health and Medical Education- Food and Drug Organization (FDA) – Islamic Republic of Iran. The Best National Entrepreneur prize was awarded to Farzan Clinical Research and Farzan was acknowledged by President of Islamic Republic of Iran in July 2011.

was established in 1890 to supply pharmaceuticals and fine chemicals to Iran, operated by the Akbarieh family ever since. Akbarieh has the expertise to work with and represent multinational companies in Iran, promoting their products and technology, importing, warehousing, sales and services of their products in our market. Our customers are the medical community, health professionals, and manufacturers of pharmaceuticals, food, cosmetic and feed industries.

Roche is a leading research-based healthcare company with combined strengths in pharmaceuticals and diagnostics. As the world’s biggest biotech company it develops truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics which already today are involved in up to 70% of therapy decisions. Roche’s broad diagnostic and bioanalytical tools not only enable innovations in science but also offer full breadth of technologies to develop new testing methods as well as companion diagnostics for Personalised Healthcare. Personalised Healthcare aims at providing the right medicine to the right patient at the right time to improve health, quality of life and survival time of patients.

The most visited news